INT131 (INT131 besylate) — Research Compounds Library | RetatrutideCompare
Selective PPAR-γ modulator developed by InteKrin. Phase 2 trials in T2D showed glycemic improvement with less weight gain and edema than full thiazolidinediones.
Selective PPAR-γ modulator developed by InteKrin. Phase 2 trials in T2D showed glycemic improvement with less weight gain and edema than full thiazolidinediones.